ENANTA PHARMACEUTICALS INC shareholders Q2 2024

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 100 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

ENANTA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,251,338$16,2307.45%
Caligan Partners LP 1,042,889$13,526,2703.16%
Soleus Capital Management, L.P. 799,546$10,370,1120.92%
Sio Capital Management, LLC 177,004$2,295,7420.62%
TANG CAPITAL MANAGEMENT LLC 300,000$3,891,0000.40%
ARMISTICE CAPITAL, LLC 1,096,000$14,215,1200.18%
BOOTHBAY FUND MANAGEMENT, LLC 483,276$6,268,0900.15%
FARALLON CAPITAL MANAGEMENT LLC 2,095,000$27,172,1500.13%
Pennant Investors, LP 35,100$455,2470.12%
Portland Global Advisors LLC 33,185$430,4090.06%
PDT Partners, LLC 36,243$470,0720.04%
Point72 Asia (Singapore) Pte. Ltd. 14,326$185,8090.04%
ACADIAN ASSET MANAGEMENT LLC 849,424$11,0140.03%
Y-Intercept (Hong Kong) Ltd 45,999$596,6070.03%
CORNERCAP INVESTMENT COUNSEL INC 13,760$178,4670.03%
Quest Partners LLC 11,588$150,2960.02%
MARSHALL WACE, LLP 928,363$12,040,8680.02%
Trexquant Investment LP 78,923$1,023,6310.02%
Clearstead Trust, LLC 5,064$65,6810.02%
Assenagon Asset Management S.A. 426,561$5,532,4960.01%
External links

This page lists ENANTA PHARMACEUTICALS INC's shareholders in Q2 2024. To view ENANTA PHARMACEUTICALS INC's shareholder history, click here.